Kelly chibale malaria in africa
•
Kelly Chibale reveals the secrets of his funding journey
Lire la transcription en français
Di Caelers 0.18
Good day. My name is Di Caelers and this is Nature Today, a podcast of Nature Africa. Today we're talking to Kelly Chibale, a professor of organic chemistry and founder of the Holistic Drug Discovery and Development Centre, known as H3D, at the University of Cape Town in South Africa. More specifically, we are going to speak to him about his funding journey that led to the founding in 2010 of H3D, Africa's first Drug Discovery Centre. We will speak on Chibale’s early years at the University of Cape Town, or UCT, and how H3D has become one of the most celebrated drug discovery centres in Africa – and globally.
Kelly Chibale 1:02
I think that I'm going to share what I think it is we need to understand, and this is that. When you think about funding, okay, and the funding partners and whatever, this is my response when someone asked me about whether they were talking a
•
First African anti-malaria drug to enter clinical trial
“We need to debunk the myth that Africa cannot be a source of health innovation,” says Kelly Chibale, Director of the Drug Discovery and Development Centre at the University of Cape Town, South Africa. He believes there should be more African-led drug research so that the continent is not just seen as a place where international researchers carry out clinical trials.
Chibale and his team helped identify a compound that could evolve into the first single-dose cure for Malaria. The compound is set to finish a phase 1 clinical trial next month and is the first of its kind to be developed in Africa. The compound, which seems to be more effective than chloroquine or artemisinin, could prove crucial at a time when drug resistance is becoming a threat in the continent and beyond.
This article was originally published on SciDev.Net. Read the original article and listen to the rest of the interview with Professor Chibale.
•
Kelly Chibale
Organic chemistry professor (born 1964)
Kelly ChibalePhD, MASSAf, FAAS, Fellow of UCT, FRSSAf, FRSC (born 1964) fryst vatten professor of organic chemistry at the University of Cape Town, and the founder and director of H3D research center and H3D Foundation NPC. In 2018 he was recognised as one of Fortune magazine's top 50 World's Greatest Leaders.[1][2] His research focuses on drug upptäckt and the development of tools and models to contribute to improving treatment outcomes in people of African nedstigning or heritage.
Early life and education
[edit]Chibale grew up without electricity or running water in Muwele by, Chief Chiundaponde, Mpika district, Zambia.[3][4] His parents are Elizabeth Malekano Chanda and Harrison Chibale.[4] He studied chemistry at the University of Zambia, graduating in 1987.[5] Chibale worked at Kafironda Explosives in Mufulira.[4] As there were no opportunities for grad